Business / Finance

RSS

Sangamo BioSciences signs definitive agreement to buy Ceregene

Sangamo BioSciences, Inc. announced that it signed a definitive agreement to acquire Ceregene, Inc., a privately held biotechnology company focused on developing adeno-associated virus gene therapies.

26 Aug 2013

INTEGRA Biosciences enters into UK market with local sales team

INTEGRA Biosciences has announced, as of August 1st 2013, a direct sales / support team in the UK to further improve support of its local customer base.

From INTEGRA Biosciences 23 Aug 2013

Mentors International, Co-Diagnostics HBDC to lower real-time PCR test prices in developing world

Mentors International and Co-Diagnostics HBDC signed an agreement to lower real-time PCR test prices in the developing world, starting with tuberculosis. Under the agreement, Co-Diagnostics HBDC will provide low-cost testing reagents and Mentors International will leverage its international connections to set up low-cost testing facilities.

23 Aug 2013

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.

23 Aug 2013

Board of Directors approve interim report for second quarter 2013

DiaGenic: The interim report for the second quarter 2013 was approved by the Board of Directors on 22 August 2013. Please find the interim report and presentation attached.

23 Aug 2013

Macrogenics Received $10M Milestone From Servier

...

22 Aug 2013

NIH Grants $5.2M To Vanderbilt Colon Cancer Investigator

...

22 Aug 2013

Takeda Launches New Subsidiary In Peru

...

22 Aug 2013

Thermo Acquisition Gets Thumbs Up From Life Tech Stockholders

...

22 Aug 2013

Psychogenics Picks Up Alzheimer’s Animal Model From USF

PsychoGenics obtained an exclusive license from the University of South Florida to its APP/PS1 double transgenic mice, which co-express the M146L presenilin 1 (PS1) mutation and the double mutations at K670N/M671L (Swedish mutation) in the amyloid precursor protein (APP).

22 Aug 2013

Caris Life Sciences to facilitate patient access to tumour profiling service in Middle East and Africa

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.

22 Aug 2013

MicuRx Pharmaceuticals raises $25 million in Series B financing

MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced it raised $25 million in Series B financing. Led by BVCF, a private equity and growth fund specializing in the life sciences industry, the round also includes existing investors Morningside Group and Devon Park Bioventures.

22 Aug 2013

Tel-Aviv Stock Exchange approves new listing of OPKO's common stock

OPKO Health, Inc. (NYSE: OPK), a multi-national biopharmaceutical and diagnostics company, today announced that the Tel-Aviv Stock Exchange ("TASE") has approved the new listing of OPKO's common stock on the TASE beginning on August 21, 2013, under the ticker symbol OPK. OPKO's common stock will thereafter be listed on both the NYSE in the United States and the TASE in Israel.

19 Aug 2013

Evogene announces financial results for second quarter and half year 2013

Evogene Ltd., a leader in plant genomics underlying crop productivity for the food, feed and biofuel industries, today announced its financial results for the second quarter and half year ended June 30, 2013.

19 Aug 2013

Illumina announces availability of its newest reagent kits for MiSeq benchtop sequencer

Illumina, Inc. today announced the availability of its newest reagent kits for the MiSeq, the industry's most accurate and easiest-to-use benchtop sequencer. The improved chemistry doubles sequencing output to 15 gigabases (Gb) by increasing the number of sequencing reads (up to 25 million reads) and overall read length (up to 2x300 base pairs). These innovations enable researchers to perform new applications including exome sequencing on the MiSeq.

From Illumina, Inc. 19 Aug 2013

Over 1,700 new chiral HPLC/SFC applications added to Phenomenex’s online resource

Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the addition of over 1,700 new chiral HPLC/SFC applications to its online resource, including more than 400 new SFC (supercritical fluid chromatography) methods. Phenomenex’s extensive chiral application database is unique in the industry, particularly with the addition of the SFC methods, which were developed in collaboration with the Department of Analytical Chemistry and Pharmaceutical Technology, Vrije Universiteit Brussel, Brussels, Belgium.

19 Aug 2013

New UV-visible spectrophotometer released by Hitachi High Technologies America, Inc.

The Life Sciences Division of Hitachi High Technologies America, Inc. released its newest UV-visible spectrophotometer, Model UH5300.

16 Aug 2013

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.

15 Aug 2013

RaySearch Laboratories announces first patient treated with RayStation

RaySearch Laboratories AB announces that the first patient in Australasia has been treated with a treatment plan created with RaySearch's treatment planning system RayStation®. The treatment was carried out at Auckland Radiation Oncology in Auckland, New Zealand.

From Elekta 13 Aug 2013

Precision Therapeutics continues its support to NOCC Pittsburgh Chapter

Precision Therapeutics will proudly continue its dedicated support to the NOCC Pittsburgh Chapter's 13th Annual Walk to Break the Silence on Ovarian Cancer. Precision has been a strong supporter of the NOCC 5 Mile Run/5 Mile & 1 Mile walk for over five years, and once again expects a great number of its employees will join together in full force to walk alongside ovarian cancer patients and survivors to help strengthen the partnerships it has forged by supporting the very cancer patients that it strives to help.

13 Aug 2013

Business / Finance

Sangamo BioSciences signs definitive agreement to buy Ceregene

INTEGRA Biosciences enters into UK market with local sales team

Mentors International, Co-Diagnostics HBDC to lower real-time PCR test prices in developing world

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Board of Directors approve interim report for second quarter 2013

Macrogenics Received $10M Milestone From Servier

NIH Grants $5.2M To Vanderbilt Colon Cancer Investigator

Takeda Launches New Subsidiary In Peru

Thermo Acquisition Gets Thumbs Up From Life Tech Stockholders

Psychogenics Picks Up Alzheimer’s Animal Model From USF

Caris Life Sciences to facilitate patient access to tumour profiling service in Middle East and Africa

MicuRx Pharmaceuticals raises $25 million in Series B financing

Tel-Aviv Stock Exchange approves new listing of OPKO's common stock

Evogene announces financial results for second quarter and half year 2013

Illumina announces availability of its newest reagent kits for MiSeq benchtop sequencer

Over 1,700 new chiral HPLC/SFC applications added to Phenomenex’s online resource

New UV-visible spectrophotometer released by Hitachi High Technologies America, Inc.

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

RaySearch Laboratories announces first patient treated with RayStation

Precision Therapeutics continues its support to NOCC Pittsburgh Chapter

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News